U.S. Biotech Stock News

In its latest reported quarter, BrightSpring Health Services generated US$3.33 billion in revenue, a 14.7% year-on-year increase that surpassed analysts’ expectations by 5.3%, and significantly exceeded forecasts for both revenue and earnings per share. This outperformance indicates stronger-than-anticipated operational execution and demand across BrightSpring’s service lines, potentially giving investors more confidence in the company’s existing growth and margin expansion plans. Next,...

Apono’s new integration with Check Point Software Technologies (CHKP) introduces a SASE-based Zero Standing Privilege model that focuses on temporary, task specific access in cloud environments, which could matter for investors watching Check Point’s security portfolio. See our latest analysis for Check Point Software Technologies. Against this backdrop, Check Point’s share price sits at US$190.76, with a 1-day share price return of 0.63% and a year to date share price return of 5.37%. Its 3...

Cinemark Holdings (CNK) has drawn fresh attention after reporting its highest domestic box office in 2025 since the pandemic began, with results surpassing both its own 2023 levels and the wider North American industry. See our latest analysis for Cinemark Holdings. Even with the recent box office headlines and brand tie ups like the National Popcorn Day promotion with Lowe's, Cinemark's share price has eased, with a 30 day share price return of 7.26% and a 1 year total shareholder return of...

Belden Inc. recently appointed Brad Dineley, formerly Vice President of Operations Excellence at TE Connectivity, as Executive Vice President Chief Digital and Operations Officer, reporting directly to the CEO from January 5, 2026. This new role, with global responsibility for digital and operations, comes as Belden seeks fresh leadership to address its recent sales and earnings stagnation. We’ll now examine how Dineley’s appointment to a newly empowered digital and operations role could...

Oncology Institute (TOI) recently drew fresh investor attention after announcing that Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, joined its Board of Directors, bringing additional healthcare and public markets experience. See our latest analysis for Oncology Institute. The board appointment comes as Oncology Institute’s share price has gained momentum, with a 21.1% 7 day share price return and a strong 1 year total shareholder return, although the 5 year...

On Holding AG recently announced that CEO and CFO Martin Hoffmann took part in a fireside chat at the 2026 ICR Conference, with a live webcast and replay made available through the company’s investor relations website. This conference appearance, alongside growing interest in its expansion beyond core running into tennis, trail, lifestyle, and apparel, has sharpened focus on how the brand’s product innovation and category diversification could shape its longer-term business outlook. Next,...

Scorpio Tankers (STNG) has drawn fresh attention after recent trading, with the share price around $56.18 and a reported value score of 6. This has put its tanker-focused business back on many investors’ watchlists. See our latest analysis for Scorpio Tankers. The recent 7 day share price return of 10.53% adds to a year to date share price return of 13.06%. The 5 year total shareholder return above 3x suggests momentum has largely built over the long run rather than just in recent...

BILL Holdings (BILL) has drawn fresh attention after recent trading left the shares around $54.55, with performance mixed across different time frames and longer term returns still negative for many holders. See our latest analysis for BILL Holdings. The recent 1 day share price return of a 3.13% decline comes after a 90 day share price return of 10.56%. The 1 year total shareholder return of a 33.87% decline shows that, despite some improving momentum in recent months, longer term holders...

If you are wondering whether Universal Health Services is attractively priced or looking stretched at around US$211 per share, this breakdown is designed to help you make sense of the numbers. The stock has seen mixed returns, with a 3.2% decline over the last 7 days and a 6.3% decline over the last 30 days, while still sitting on gains of 11.4% over 1 year, 46.5% over 3 years, and 62.3% over 5 years. Recent share price moves have kept Universal Health Services on the radar for investors who...

Piper Sandler recently upgraded HF Sinclair to Overweight, highlighting the refiner’s exposure to a tighter West Coast market and a more constructive refining backdrop for 2026. The broker framed HF Sinclair as a “mini-large cap” among smaller refiners, underscoring its perceived resilience and relative appeal within the group. We’ll now examine how this increased confidence in HF Sinclair’s West Coast refining leverage could influence the company’s broader investment narrative. Trump's oil...

Kura Sushi USA (KRUS) has just opened fiscal 2026 with Q1 results that sit against a backdrop of growing scale and still thin profitability, with investors weighing its US$64.93 share price against a trailing twelve month revenue base of US$282.8 million and a net loss of US$1.9 million. Over the past year, revenue has moved from US$237.9 million in the twelve months to Q4 2024 to US$282.8 million in the twelve months to Q4 2025. Over that same period, basic EPS has shifted from a loss of...

If you are wondering whether SoFi Technologies' share price still makes sense after a strong run, this article walks through what the current market price might be implying about the business. The stock last closed at US$27.72, with returns of 5.9% over 7 days, 3.3% over 30 days, 0.9% year to date and 90.5% over the past year. The 3 year return sits at a very large 417.2%, and the 5 year return at 44.7%. Recent attention on SoFi has been shaped by ongoing discussion around its role as a...

What Brookdale Senior Living’s Recent Returns Say About Investor Focus Brookdale Senior Living (BKD) has drawn fresh attention after a stretch of mixed share performance, with a 0.4% decline over the past day contrasting with gains over the past week, month, and past 3 months. See our latest analysis for Brookdale Senior Living. That 0.4% one day share price dip sits against a stronger pattern, with a 30.4% 3 month share price return and a very large 1 year total shareholder return that...

If you are wondering whether Nucor's current share price reflects its true worth, you are not alone. This article is built to help you make sense of what you are paying for. Nucor's stock recently closed at US$167.88, with returns of 2.9% over 7 days, 6.2% over 30 days, a 0.9% decline year to date, and 44.4% over the last year, which naturally raises questions about how much of this is already priced in. Recent market attention on Nucor has centered on its position as a major U.S. steel...

Stanley Black & Decker (SWK) is back in focus after reporting quarterly revenues of US$3.76b that were flat year on year, along with an earnings beat but slightly softer full year EPS guidance. See our latest analysis for Stanley Black & Decker. The results-driven rally has lifted Stanley Black & Decker’s share price to US$81.49, with a 1-day share price return of 3.56% and a 90-day share price return of 26.48%, while the 5-year total shareholder return decline of 44.50% shows longer term...

Grab Holdings (GRAB) has moved deeper into automation after acquiring Chinese AI robotics firm Infermove, adding to new logistics alliances and regulatory approval to test autonomous vehicles in Singapore, which together have lifted market attention. See our latest analysis for Grab Holdings. Despite a recent 1 month share price return of 5.24% decline and a 90 day share price return of 16.72% decline from the latest close of US$4.88, the 1 year total shareholder return of 5.40% and 3 year...

In recent days, several major Wall Street firms reiterated their views on Schneider National, with Susquehanna, Wells Fargo, B of A Securities and Citi all updating their research coverage and maintaining generally cautious-but-constructive ratings on the trucking and logistics group. These analyst moves have drawn fresh attention to Schneider as a fundamentals-focused operator with a large multimodal freight network and a track record of paying regular dividends rather than chasing...

Dycom Industries (DY) is back in focus after the company paired upbeat multi‑year guidance with analyst rating reaffirmations, all tied to continued demand for fiber, data center, and rural broadband infrastructure work. See our latest analysis for Dycom Industries. That upbeat multi year outlook and recent analyst commentary come after a strong run, with the share price at US$339.68 and a 90 day share price return of 19.47%, while the 1 year total shareholder return of 89.77% points to...

Sirius XM Holdings recently renewed Howard Stern's contract through 2028, appointed Zachary Coughlin as chief financial officer, and continued to receive backing from major shareholder Berkshire Hathaway, which has increased its stake while the company pursues cost cuts and ad-supported streaming partnerships. Together, these moves secure marquee content, sharpen the focus on profitability, and signal institutional confidence in Sirius XM’s efforts to reshape its audio business model. We’ll...

If you are looking at Asbury Automotive Group and wondering whether the current share price reflects its true value, you are in the right place for a clear valuation checkup. The stock last closed at US$250.65, with reported returns of 7.8% over 7 days, 5.4% over 30 days, 6.8% year to date, 3.6% over 1 year, 29.5% over 3 years and 51.6% over 5 years. This gives investors some context before comparing price to value. Recent news around Asbury Automotive Group has focused on its position...

Neogen (NEOG) has just put Q2 2026 under the microscope with total revenue of US$209.2 million and basic EPS of US$0.17, providing a clear snapshot of where the business sits after a stretch of heavy losses. The company has seen quarterly revenue move from US$216.9 million in Q1 2025 to US$231.3 million in Q2 2025, then US$220.98 million in Q3 and US$225.5 million in Q4 2025 before landing at US$209.2 million in Q1 2026. Over the same periods, basic EPS went from a loss of US$0.06 to losses...

Legend Biotech (LEGN) moved higher after Oppenheimer initiated coverage, highlighting Carvykti’s performance compared with other CAR-T therapies and noting profitability expectations for 2026 ahead of the company’s J.P. Morgan Healthcare Conference presentation. See our latest analysis for Legend Biotech. At a share price of $23.03, Legend Biotech’s 1-day and 7-day share price returns of 1.36% and 5.93% sit against a 90-day share price return of 27.35% decline and a 1-year total shareholder...

If you are wondering whether PAR Technology at around US$37.19 is priced attractively or not, you are in the right place for a clear look at what that tag might actually represent. The stock has seen mixed returns, with gains of 2.5% over the last week, 4.6% over the last month and 4.1% year to date, set against a 45.4% decline over the past year and 46.9% over five years. This raises questions about how the market currently views its risk and potential. Recent attention around PAR...

In late 2025, Klarna, the global digital bank and flexible payments provider, released survey results showing many Americans struggle to understand and manage post-holiday credit card bills, including how much they owe and how long repayment will take. The company used these findings to position its buy now, pay later products as offering clearer budgeting and greater control than traditional revolving credit cards, directly addressing consumer anxiety around debt. With Klarna spotlighting...